Marek Dynowski

IT and Scientific Computing Core Facility Manager

Manager of the IT and Scientific Computing Core Facility which supports large-scale data processing, management and storage for research as well as day-to-day computing needs across the Institute

About Marek Dynowski

As manager of our IT and Scientific Computing Core Facility, Marek has overseen the construction of a brand-new data centre in the Paterson Building, which serves the day-to-day and advanced scientific computing needs of the Institute.

Marek’s focus is on making the wide variety of resources provided more accessible to researchers.  Using Tools like RStudio Web server, the Galaxy web-based platform for data-intensive biomedical research and technologies like Remote Desktop Access via XRDP are simplifying the usage of High Performance Clusters like Griffin.

He is interested in helping researchers understand the software they are using, the best ways to store, analyse and manage their data Therefore, and so the IT and Scientific Computing team is working closely with the Computational Biology Support team and the Bioinformatics and Biostatistics team from the National Biomarker Centre on training programmes to ensure users have the essential knowledge needed to use these powerful resources.

Marek is also interested in cyber security, overseeing updates and maintenance of the Facility’s perimeter firewall,and thoroughly reviewing infrastructure and security protocols, including the implementation of two-factor authentication.

His team support secure methods for external collaborators to access Institute’s services, which is crucial for maximising the Paterson Building’s potential, where scientists from multiple organisations collaborate.

Interests

  • High performance computing
  • Scientific data management
  • Cyber security and data protection
  • Researcher training
Gloved hands filling a stripette white lab coat

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Leukaemia Immunology & Transplantation

The Leukaemia Immunology and Transplantation laboratory aim to develop a comprehensive strategy to prevent post-transplant relapse in patients treated with allogeneic haematopoietic stem cell transplantation – the only curative therapy for many patients with acute myeloid leukaemia (AML) and other poor-risk haematological malignancies.

Patient derived preclinical models reveal novel biology of SCLC

Immune detection of dying tumour cells can elicit cancer immunity when the host permits it

Cancer Research In the Paterson Building
Leukaemia Immunology & Transplantation
Patient derived preclinical models reveal novel biology of SCLC